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Abstract 
 
 Aim: 
To assess the correlation between measured and estimated GFR in voluntary kidney donors, pre and post 
nephrectomy and to determine the post-nephrectomy GFR in VKDs. 
Materials and methods: 
Pre- and post-nephrectomy (after 3 months) GFR measurement was done by 99mTcDTPA scintigraphy and 
estimations using creatinine (CG, MDRD formulae) and serum Cystatin C (Grubb’s equation).  
Discussion: 
Forty-three donors (15 males, mean age of 43.02 ± 12.05 years) were studied. CG estimations used actual 
and lean body weight (CGGFRA, CGGFRL). Modification of diet in renal diseases formula used MDRD1 
and MDRD2 formulae. The measured values were 92.37 ± 26.79-ml/min/1.73 m2 at baseline and 53.58 ± 
17.18-ml/min/1.73 m2 after 3 months. The estimated values at the same time points by CGGFRA, 
CGGFRL, MDRD1 and MDRD2 were 78.34 ±16.30, 58.12 ±12.35, 84.61± 15.68, 90.82 ± 19.29 
ml/min/1.73 m2 respectively, pre-nephrectomy and 56.78 ± 12.90, 42.42 ± 10.00, 62.07 ± 11.34 61.67 ± 
12.33 ml/min/1.73 m2 respectively, post-nephrectomy. As CysC is better predictor of changes in GFR, it 
was performed in a subset (n=21). The Pre- and post- nephrectomy CysC GFR using the Grubb’s equation 
was 90.48 ± 28.04 and 56.73 ± 15.87- ml/min/1.73 m2. Significant intraclass correlation coefficient was 
noted between 99mTCDTPA GFR and CysCGFR (0.83 and 0.67, pre and post), but not with others. CG and 
MDRD GFRs had correlation. Post-nephrectomy GFR decline by all methods were significant with 
99mTCDTPA GFR (41.99%) recording the maximum decline. 
 
Conclusion: 
Cystatin C GFR predicts 99mTC-DTPA GFR reasonably well, pre- and post-nephrectomy. Creatinine based 
estimated GFRs don’t. However, CG and MDRD have acceptable correlation between them. 
The post-nephrectomy decline in the GFR was significant by all methods with the highest decline noted 
with 99m TC-DTPA. 
 iv 
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Introduction 
The assessment of renal functions has always remained a challenge for 
nephrologists. The accurate assessment is paramount for several reasons like categorizing 
patients into the different groups, comparison of renal function amongst different 
populations, determining the therapeutic measures needed at different categories of renal 
dysfunction in chronic kidney disease patients and so on. The simple measurement of 
plasma creatinine and the estimated glomerular filtration rate (GFR) using the various 
equations have been the mainstay of renal function assessment in the bedside.  The other 
methods of direct measurement are cumbersome to perform on a day-to-day basis and are 
quite expensive. This has forced the nephrology community to accept the former 
(compromising on the accuracy) to that of the latter methods. Several new methods like 
the technetium 99m-labeled diethylene triaminopentaacetic acid (99mTc-DTPA) renal 
scintigraphy have been claimed to measure GFR accurately. But these have not been 
standardized. Also various biochemical markers like cystatin C (CysC) and beta- 2 
microglobulin have been claimed to reflect smaller degrees of renal changes better but 
have not come into widespread clinical use. 
Another major implication of the GFR is in knowing the renal function of 
voluntary kidney donors (VKD).  Knowing that there will be a 50% drop in GFR after the 
donor nephrectomy, these patients are at a risk when faced with an adverse situation. 
However, the kidney also has the capacity to remodel itself for the loss and increase its 
GFR in the remnant kidney. This has been studied previously using different methods. 
But there are no consensus recommendations as to the method that has to be used and the 
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applicability of various prediction equations in calculating GFR in donors after the 
nephrectomy. 
Our study looks at the comparability of the various estimation equations to the 
99mTc-DTPA GFR in the pre- and post-nephrectomy situations in VKD and also the renal 
adaptation after the nephrectomy. This data was studied after 3 months of nephrectomy in 
a stable state and the degree of renal adaptation is quantified.  We have also used CysC as 
a marker for estimating GFR and also compared its suitability in these two settings, as it 
is considered a more reliable marker in reflecting small changes in renal functions than 
creatinine.  
 
 
 
 
 
 
 
 
 
 3
Objectives of the study 
1. To compare the measured GFR (99mTc DTPA) and the estimated GFR (Creatinine 
and Cystatin C) by various methods in voluntary kidney donors. 
a. Before donor nephrectomy  
b. After donor nephrectomy 
2. To analyze the consistency of the various methods to assess the decline in GFR. 
3. To study the residual GFR of the solitary kidney after compensation (after 3 
months and before 6 months of nephrectomy). 
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Review of literature 
Section I 
The two major functions of the kidneys are: 
1. Maintenance of milieu interior: It participates in the maintenance of the 
constant extra cellular environment that is required for adequate functioning of the cells. 
This is achieved by excretion of some of the waste products of metabolism like urea, 
creatinine, and uric acid and by specifically adjusting the urinary excretion of water and 
electrolytes to match net intake and endogenous production. The kidney is able to 
regulate individually the excretion of water and solutes such as sodium, potassium, and 
hydrogen, largely by changes in tubular reabsorption or secretion.  
2. Endocrine hormones synthesis: It secretes hormones that participate in the 
regulation of systemic and renal hemodynamics (renin, prostaglandins, and bradykinin), 
red blood cell production (erythropoietin), and calcium, phosphorus, and bone 
metabolism (1,25-dihydroxyvitamin D3). 
The renal patients 
Patients with renal disease may have a variety of different clinical presentations. 
Some have symptoms that are directly referable to the kidney (gross hematuria, flank 
pain) or the extrarenal organs (edema, hypertension, signs of uremia). Many patients, 
however, are asymptomatic and are picked up on routine medical examination for 
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unrelated illnesses or by a laboratory evaluation showing an elevated plasma creatinine 
concentration or an abnormal urinalysis. 
After the diagnosis of renal disease, the quantification of renal function is done. 
Estimation of the GFR is used clinically to assess the degree of renal impairment 
and to follow the course of the disease. However, the GFR provides no information on 
the cause of the renal disease. This is achieved by the urinalysis and, if necessary, 
radiological studies and a renal biopsy. 
EVALUATION OF THE GLOMERULAR FILTRATION RATE  
The GFR is equal to the sum of the filtration rates in all of the functioning 
nephrons. Thus, estimation of the GFR gives a rough measure of the number of 
functioning nephrons in the kidney. A reduction in GFR implies either progression of the 
primary disease or the development of a superimposed secondary pathology or more 
commonly, a reversible problem, such as decreased renal perfusion due to volume 
depletion, nephrotoxic medication, infection or obstruction. An increase in GFR, on the 
other hand, is indicative of improvement in renal function, whereas a stable GFR implies 
stable disease. However, there is no exact correlation between the loss of renal mass and 
the loss of renal function. Since the kidney adapts to loss in function by compensatory 
hyperfiltration and/ or increasing solute and water reabsorption in the remaining normal 
nephrons (single nephron GFR), an individual with the loss of one-half of the total renal 
mass does not necessarily have one-half the amount of normal renal function.  
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Glomerular filtration rate cannot be measured directly. The gold standard for 
estimation involves the assessment of clearance of inulin. Inulin is a physiologically inert 
substance that is freely filtered at the glomerulus, and is neither secreted, reabsorbed, 
synthesized, nor metabolized by the kidney. These act as important properties for exact 
measurement of GFR and any substance used for measuring GFR should fulfill these 
attributes and hence are usually compared to inulin.  
Thus, the amount of that substance filtered at the glomerulus is equal to the 
amount excreted in the urine, which can be measured. Accurate determination of the GFR 
is also possible using the clearance of a radiolabelled compound such as radiolabelled 
iothalamate, DTPA, or ethylene diamino tetraacetic acid (EDTA) 1. Radiocontrast agents 
like Iohexol and non-radiolabelled iothalamate are also useful for this purpose1. 
All these methods are impractical on a regular basis and the expenses are often a limiting 
factor.  
In day-to-day practice, the most common methods utilized to estimate the GFR 
are the plasma creatinine concentration, the creatinine clearance, and estimation 
equations based upon the plasma creatinine concentration, namely the Cockcroft-Gault 
(CG) equation2 and Modification of Diet in Renal Disease (MDRD) equations3. The 
abbreviated MDRD equation, a simplified version, in particular, is being increasingly 
utilized4.  
 
The Kidney/Dialysis Outcome Quality Initiative (K/DOQI) guidelines5 have 
published recommendations on classifying patients by chronic kidney disease stage, 
which is defined in part on the estimation of the GFR. They also recommend that the 
level of GFR should be estimated from prediction equations that take into account the 
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serum creatinine concentration and some or all of the following variables: age, gender, 
race, and body size. In adults, the MDRD Study equation and Cockcroft-Gault equations 
are recommended.  In children, the Schwartz formula6 and the Counahan- Barratt 
equations7 are most popular. 
Methods of Assessing GFR 
The advantages and disadvantages of the various methods used to assess GFR are 
described low. 
Methods based on principle of clearance of substances 
 
a) Inulin clearance 
Inulin is considered the gold standard but is not in contemporary use because of 
its scarcity and the cost. It is a polymer of fructose found in tubers like dahlia and 
chicory. It is an inert compound and is readily measured by colorimetric assays. Glucose 
is also detected in these assays and hence should be removed prior to the assay to prevent 
false positive results.  Homer Smith8 originally developed the renal clearance method. 
Patients are studied in the morning after an overnight fast. An oral water load of 10 to 15 
ml per kg body weight is administered prior to infusion and additional water is 
administered throughout the test to ensure a constant urinary flow of 4 ml/min. Once 
steady state is achieved, several timed samples are taken. Ideally, the bladder needs 
catheterization. Serial plasma levels are also measured.  
Usually an average of three to five separate determinations has to be made. 
However, each of these measurements is subject to inaccuracies. The coefficient of 
variation between clearance periods is 10% and the coefficient of variation of inulin 
clearance measured on different days on the same individual is approximately 7.5%9. 
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To avoid problems related to urine collection, many investigators have turned to 
plasma clearance techniques. Plasma clearance of inulin can be measured with the use of 
either a constant infusion or a bolus injection10. If during a constant infusion both the 
distribution space and the plasma level of inulin are constant, the rate of infusion is equal 
to the rate of elimination. The inulin clearance then becomes the rate of infusion divided 
by the plasma concentration. There is a high degree of correlation between results from 
this technique and those from the renal clearance method10. However, maintaining 
constant plasma concentrations is very difficult11, 12 and the constant infusion technique is 
rarely used. 
Thus, a number of problems limit the usefulness of inulin clearance as a marker of 
GFR. Although most data indicate that inulin is freely filtered and is not handled by the 
renal tubules, this indication may not be true for all clinical situations. For example, it has 
been suggested that impaired filtration, back-diffusion of inulin, or both can limit the 
usefulness of this marker in kidney transplant recipients13. 
These logistic reasons along with the cost and lack of availability have made 
inulin clearance a test of the past. 
b) Creatinine clearance 
Creatinine is derived from the metabolism of creatine in skeletal muscle and from 
dietary meat intake. It is released into the circulation at a relatively constant rate and has 
a stable plasma concentration. Creatinine is freely filtered across the glomerulus and is 
neither reabsorbed nor metabolized by the kidney. Hence, it is used as an endogenous 
marker. However, approximately 15 percent of urinary creatinine is derived from tubular 
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secretion by the organic cation secretory pathways in the proximal tubule14 and this value 
may increase in settings of renal failure. 
The effect of secretion is usually ignored for day-to-day use. Then, all of the 
filtered creatinine (product of the GFR and the plasma creatinine concentration [PCr]) 
will be excreted (product of the urine creatinine concentration [UCr] and the urine flow 
rate [V]). Thus: 
  GFR x PCr = UCr x V  
  GFR    =    [UCr x V]/PCr  
This formula is more aptly called the creatinine clearance and tends to exceed 
the true GFR by the 10 to 15 percent of urinary creatinine that is derived from tubular 
secretion15. Fortunately, this error is balanced by an error of almost equal magnitude in 
the measurement of the Pcr in the laboratory. The creatinine clearance is usually 
determined from a 24-hour urine collection. Shorter collections tend to give less accurate 
results. The normal value for the creatinine clearance is 95 ± 20 ml/min in women and 
120 ± 25 ml/min in men15. 
Limitations with creatinine clearance  
The major errors limiting the accuracy of the creatinine clearance are: 
• An incomplete urine collection 
• Increasing creatinine secretion 
 10
An incomplete urine collection  
 The completeness of the collection can be estimated from knowledge of the 
normal rate of creatinine excretion (which is equal to creatinine production in the steady 
state). In adults under the age of 50, daily creatinine excretion should be 20 to 25 mg/kg 
(177 to 221 µmol/kg) of lean body weight in men and 15 to 20 mg/kg (133 to 177 
µmol/kg) of lean body weight in women. From the ages of 50 to 90, there is a progressive 
50 percent decline in creatinine excretion (to about 10 mg/kg in men), due primarily to a 
fall in muscle mass.  
Increasing creatinine secretion 
The accuracy of the creatinine clearance is also limited by the fact that as the GFR 
falls, the rise in the PCr is partially ameliorated by enhanced creatinine secretion16. As an 
example, as the true GFR falls to a range of 40 to 80 ml/min (as measured by alternative 
modalities), the absolute amount of creatinine secreted can rise by more than 50 percent, 
accounting for as much as 35 percent of urinary creatinine15.  
Thus, creatinine excretion is much greater than the filtered load, resulting in a 
potentially large overestimation of the GFR. The net effect is that the creatinine clearance 
may be normal (>90 ml/min) in about one-half of patients with a true GFR of 61 to 70 
ml/min and one-quarter of those with a true GFR of 51 to 60 ml/min17. Some patients 
with advanced disease have a creatinine clearance that exceeds the GFR by more than 
twofold. 
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From the above considerations, all that can be concluded is that the creatinine 
clearance represents an upper limit of what the true GFR may be. More accurate 
determination of the GFR requires some other modality using a radiolabelled compound 
such as iothalamate, DTPA, or EDTA. The radioisotopes undergo a small degree of 
tubular secretion, but they only overestimate the GFR by a few ml/min in patients with 
underlying renal insufficiency. 
 Drugs like trimethoprim and cimetidine compete and block the pathways of 
creatinine excretion in the renal tubules. Thus the creatinine that is excreted is derived 
exclusively from the glomerular filtration18, 19. These methods improve the sensitivity, but 
are not very popular. 
In early renal disease when the GFR is still near normal, an initial decline in GFR 
may lead to only a slight increase (0.1 to 0.2 mg/dl [9 to 18 µmol/L]) in the PCr because 
of an increase in proximal tubular creatinine secretion. The net effect is that patients with 
a true GFR as low as 60 to 80 ml/min (as measured by the clearance of a true filtration 
marker such as inulin or radioisotopic iothalamate or DTPA) may still have a PCr that is 
1.0 mg/dl (88 µmol/L) 14, 20. Thus, a relatively stable PCr in the normal or near-normal 
range does not necessarily imply that the disease is stable. However, once the PCr 
exceeds 1.5 to 2 mg/dl (132 to 176 µmol/L), the secretory process is effectively saturated 
and a stable value usually does represent a stable GFR14.  
Limited data also suggests that tubular secretion is significant in patients with the 
nephrotic syndrome. In one study based upon a determination of GFR by inulin 
clearance, decreased serum albumin levels were associated with a marked increase in 
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tubular creatinine secretion (36 ml/min per 1.73 m2 for nephrotic patients with serum 
albumin levels less than 2.6 g/dl versus 11 ml/min per 1.73 m2 for normal controls) 21.  
The degree of creatinine secretion may vary with time, affecting the PCr 
independent of the GFR. In effectively treated lupus nephritis, for example, a rise in the 
GFR may not be accompanied by the expected reduction in the PCr due to a fall (via an 
uncertain mechanism) in creatinine secretion 22. In this setting, decreased activity of the 
urine sediment, diminished protein excretion, and lack of further elevation in the PCr all 
point toward possible improvement. 
There are certain settings in which there may be an acute increase in creatinine 
production. One example is a recent meat meal. In addition, it has been suggested that the 
plasma creatinine concentration rises more rapidly with rhabdomyolysis (up to 2.5 mg/dl 
or 220 µmol/L per day) than with other causes of acute renal failure23. 
The presence of certain drugs may increase the plasma level of the serum 
creatinine by decreasing creatinine secretion. This includes trimethoprim (which is most 
often given in combination with sulfamethoxazole) and the histamine 2-blocker 
cimetidine, which result in a self-limited and reversible rise in the PCr of as much as 0.4 
to 0.5 mg/dl (35 to 44 µmol/l). Certain substances may interfere with the plasma assay; 
thereby artifactually increasing the plasma is secreted by the same pathway. 
Thus, with both the clearance methods having problems, we are left with other 
methods to estimate GFR.  
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Measurements of substances from plasma 
a) Plasma creatinine 
As previously mentioned, creatinine excretion (GFR x PCr) equals creatinine 
production in the steady state and that creatinine production is relatively constant. Thus 
  GFR x PCr    = constant  
Figure 1: Correlation between serum creatinine and GFR 
Thus, the plasma creatinine concentration varies inversely with the GFR (Fig.1). 
If, for example, the GFR declines by about 50 percent, the creatinine excretion will 
initially be reduced. This will lead to creatinine retention and a rise in the PCr until the 
latter has doubled. At this point, the filtered load will again be equal to excretion. 
  GFR/2 x 2PCr    = GFR x PCr    = Constant  
A rise in PCr almost always represents a reduction in GFR. But there are 
exceptions like drugs that interfere with either creatinine secretion or the assay used to 
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measure the PCr or possibly in patients with rhabdomyolysis. In these settings, there will 
be no change in GFR and no concurrent elevation in the BUN. The other factors that 
might influence plasma creatinine are summarized below (Table 1). 
Table 1: Factors affecting the Serum creatinine levels 
Factor Effect on serum creatinine 
Aging Decreased 
Female sex Decreased 
Race  
      Black Increased 
     Hispanic Decreased 
     Asian Decreased 
Body habitus  
Muscular Increased 
Amputation Decreased 
Obesity No change 
Chronic illness  
    Malnutrition Decreased 
   Neuromuscular illness Decreased 
Diet  
   Vegetarian Decreased 
   Cooked meat Increased 
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Based on the third National Health and Nutrition Examination Survey, among 
individuals without hypertension or diabetes in the United States, the mean PCr values 
for men and women were 1.13 and 0.93 mg/dl (100 and 82 µmol/L), respectively24.  
The value is lower in women because they have less muscle and therefore a lower 
rate of creatinine production.  
Limitations with plasma creatinine values 
A rising PCr implies disease progression, a falling level indicates improvement, 
and a stable value usually reflects stable disease. However, as with the creatinine 
clearance, there are several exceptions. Plasma creatinine is most often measured by the 
alkaline picrate method. This colorimetric assay can recognize other compounds as 
creatinine chromogens, particularly acetoacetate in diabetic ketoacidosis25. In this setting, 
the PCr can rise by 0.5 to 2 mg/dl or more. Modern autoanalyzers use serum creatinine 
assays with less interference by non-creatinine chromogens (for example, kinetic alkaline 
picrate or enzymatic methods, such as the imidohydrolase method). 
Extrarenal creatinine clearance is increased in advanced renal failure when the 
plasma creatinine concentration is greater than 6 mg/dL (530 µmol/L). In this setting, 
there is intestinal bacterial overgrowth and increased bacterial creatininase activity26. As 
a result, the plasma creatinine concentration is lower than would be expected from the 
glomerular filtration rate.  
As previously mentioned, laboratories with calibration differences can provide 
varying plasma creatinine concentration measurements that can lead to erroneous 
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estimations of GFR in patients with relatively normal plasma creatinine concentrations27. 
Differences in method and equipment may also affect plasma creatinine concentration. 
In summary, serum creatinine is affected by the level of GFR and by factors 
independent of GFR, including age, gender, race, body size, and diet, certain drugs, and 
laboratory analytical methods. Therefore, serum creatinine is not an accurate index of the 
level of kidney function, and the level of serum creatinine alone should not be used to 
assess the stage of chronic kidney disease. 
However, till date this investigation modality remains the most convenient for 
day-to day use. 
b) Estimation equations using creatinine 
Several formulas that utilize easily obtained values (such as creatinine) have been 
developed to help estimate the GFR. Equations have the advantage of providing an 
estimate of GFR that empirically combines all of these average effects while allowing for 
the marked differences in creatinine production between individuals. These include the 
Cockcroft-Gault2 and Modification of Diet in Renal Disease 3,4 equations. The MDRD 
equations, particularly the abbreviated version, are being increasingly utilized, as 
recommended by the K/DOQI guidelines. 
This illustration given below shows the association between the GFR measured 
by CG method and the iothalamate based GFR (Fig 2). 
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Figure 2: Correlation between CG GFR and the iothalamate GFR 
Requirement for stable renal function 
These formulae can only be used only in patients with stable renal function. Thus, 
these formulae are not accurate in patients with acute renal failure, where a steady state 
does not exist. Some other equations claim accuracy in these settings, but are not popular. 
i) Cockcroft- Gault formula 
The CG equation allows the creatinine clearance to be estimated: 
  a) Men: CrCl = [(140-age)∗ Weight (Kg)]/[SCr ∗ 72] 
  b) Women: CrCl = [(140-age)∗ Weight (Kg)]/[SCr ∗ 72] *85/100 
This formula takes into account the increase in creatinine production with 
increasing weight, and the decline in creatinine production with age. For women, the 
formula requires multiplication by 0.85 to account for smaller muscle mass compared to 
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men. The GFR is calculated by multiplying this creatinine clearance by a factor of 0.8428. 
The CG equation does not include body size and is not standardized to the body surface 
area. It has been suggested that the lean body weight be used rather than actual weight, 
especially for obese individuals. 
ii) Modification of Diet in Renal Disease equations  
The MDRD equation was based upon data obtained from the MDRD study that 
measured GFR using the clearance of iothalamate.  
The MDRD Study equation has the advantages of having been derived based on:  
• GFR measured directly by urinary clearance of 125I-Iothalamate 
• A large sample of >500 individuals with a wide range of kidney diseases 
• Inclusion of both European-American and African-American participants 
• Validated in a large (n > 500) separate group of individuals as part of its 
development 
 In addition to the plasma creatinine, the equation uses age, serum albumin 
concentration, and blood urea nitrogen value to estimate the GFR: 
    GFR, in ml/min per 1.73 m2   = 170 x (PCr [mg/dl]) [-0.999] x  
      (Age) [-0.176] x (BUN [mg/dl]) [-0.170] x  
      (Alb [g/dl]) [+0.318] x (0.762 if female) x (1.18 if black)  
PCr = plasma creatinine concentration, BUN = blood urea nitrogen concentration.  
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The following simplified or abbreviated MDRD equation to estimate the GFR has 
also been developed using data from the MDRD study4: 
    GFR, in ml/min per 1.73 m2   = 186.3 x PCr [-1.154] x  
      Age [-0.203] x (0.742 if female) x (1.21 if black)  
The MDRD equations were derived from patients (largely white and black) with 
nondiabetic renal disease (mean GFR of 40 mL/min per 1.73 m2) who were enrolled in 
the MDRD study from the United States. As a result, they can be reliably used in such 
patients with significant renal dysfunction The National Kidney Foundation5 and the 
European best practice guidelines29 endorse the use of this equation. They have also been 
found to be accurate in African-Americans and those with diabetic renal disease. 
However it has not been standardized in the Indian population. 
Both the abbreviated MDRD formula and the CG equations provide similar 
values within a wide-range of patient ages. As part of the third National Health and 
Nutrition Examination Survey (NHANES III), the GFRs and creatinine clearances were 
estimated with the simplified MDRD formula and the CG equation, respectively30. 
Within the 5th to 95th percentile range for age, both estimation equations provided 
similar measurements, which were consistent with age-specific historic inulin clearance 
values. 
The CG equation provided higher estimates at younger ages and lower estimates 
at older ages (eg. greater than 70 years of age) than that obtained with the simplified 
MDRD formula. 
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iii) Other estimation equations 
Besides these, several other equations have been published. But they are not in 
widespread use. They are summarized in the figure 3. 
 
Figure 3. Various estimation equations (adapted from K/DOQI guidelines) 
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Limitations in estimation equations 
The MDRD formula and CG equation have several limitations.  
1. They are known to be less accurate in populations without chronic kidney 
disease; examples being young patients with type 1 diabetes without microalbuminuria 
and in voluntary kidney donors31, 32. 
2. Estimation equations are not reliable for estimation of GFR in individuals with 
significant variations in dietary intake (vegetarian diet, creatinine supplements) or muscle 
mass (amputation, malnutrition, muscle wasting), since these factors are not specifically 
taken into account in prediction equations. 
3. In the case of amputations, the accuracy of estimation equations is affected to a 
greater extent among lower extremity amputees, given the much greater reduction in 
muscle mass, compared to upper extremity amputations. In these situations, collection of 
a 24-hour urine sample for measurement of creatinine clearance, or measurement of 
clearance of an exogenous filtration marker, provide better estimates of GFR than 
prediction equations. Some studies have advised correctional indices for these situations, 
but they are not accurate. 
With respect to recipients of renal allografts, there have been variable results related 
to the accuracy of the MDRD equations: 
• In a study comprising 798 patients by Bosma et al33; comparison of renal 
function derived from nine equations with the GFR directly measured by 
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iothalamate was made. The MDRD and Jelliffe 234 equations were the 
relatively best predictors of GFR; the predictive performance was only modest 
for all equations.  
• In two studies, the MDRD equation was the most accurate among the 
evaluated formulas, although not more than 45 to 55 percent of estimated 
values with the MDRD equation were within 10 to 20 percent of actual 
measured GFR31, 35. 
Thus, although the MDRD has limitations in transplant recipients, it can still be 
used in this setting. 
The accuracy of these formulae in patient populations from outside the United 
States is also unclear. As examples, some evidence suggests that the use of the MDRD 
formulas and the CG equation may result in somewhat inaccurate estimations of kidney 
function in some European, Indian and Chinese patient populations with chronic kidney 
disease. One such study from India concluded that the error and the correlation are poor 
making them suboptimal for use36. 
Thus, these studies found that ethnicity influences the accuracy of the CG or 
MDRD formulas. These formulae appeared to generally overestimate the GFR in patients 
with stage 4 and 5 disease. In such patients with marked renal failure, a complementary 
method may be, to obtain the average of both the creatinine and urea clearances37.  
In summary, the estimation equations have not been validated in all races and 
seem to be less accurate in certain populations. These include individuals with high, 
normal, or near-normal renal function, children, patients older than 70 years of age, other 
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ethnic groups, pregnant woman, and those with unusual muscle mass, body habitus, and 
weight (eg. morbid obesity, amputees).  
c) Urea and the GFR 
Urea also varies inversely with the GFR. But, it is generally less useful than the 
plasma creatinine because the urea changes are independent of the GFR. Two factors 
contribute to this phenomenon: 
• The rate of urea production is not constant. It increases with dietary protein and with 
enhanced tissue breakdown due to hemorrhage, trauma, or corticosteroids. By 
comparison, a low protein diet or liver disease can lower the urea without change in GFR.  
• Urea is also significantly reabsorbed in the tubules. Approximately 40 to 50 percent 
of the filtered urea is passively reabsorbed, mostly in the proximal tubule. Thus, when 
volume depletion is associated with enhanced proximal sodium and water reabsorption, 
there is a parallel increase in urea reabsorption. So, the urea will be elevated out of 
proportion to any change in GFR and therefore to any change in the creatinine. This 
elevation in the urea/PCr ratio is one of the suggestive clinical signs of decreased renal 
perfusion (prerenal disease) as the cause for renal failure.  
However, the measurement of the clearance of urea is useful in one setting. 
Among patients with significant renal insufficiency (eg. a PCr greater than 4 mg/dL), the 
urea clearance significantly underestimates the GFR. Since the creatinine clearance 
significantly overestimates this function, one method to estimate the GFR in these 
patients is to average both the creatinine and urea clearances38. 
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                         GFR    =    (Creatinine clearance+ Urea clearance)/2  
 
The 2005 European Best Practices Guidelines suggest that this calculation is preferred for 
estimating GFR in advanced renal failure. This method is utilized for renal function 
evaluation in patients on Continuous Ambulatory Peritoneal Dialysis. 
As previously mentioned, the MDRD equation can also be used in those with significant 
renal dysfunction39.  
Newer compounds and methods 
a) Plasma cystatin C (CysC) 
CysC is a 122-amino acid, 13-kDa protein that is a member of the family of 
cysteine proteinase inhibitors. Simonsen and coworkers first suggested its use in 198540. 
It is the product of a "housekeeping" gene expressed in all nucleated cells and is produced 
at a constant rate41, 42. Because of its small size and basic pI ( 9.0), CysC is freely filtered 
by the glomerulus. It is not secreted, but is reabsorbed by tubular epithelial cells and 
subsequently catabolized so that it does not return to the blood flow. This latter property 
negates calculation of a CysC clearance using urine concentrations of CysC. The use of 
serum CysC to estimate GFR is based on the same logic as the use of blood urea nitrogen 
and creatinine, but because it does not return to the bloodstream and is not secreted by 
renal tubules, it has been suggested to be closer to the "ideal" endogenous marker.  
All nucleated cells produce CysC. Its rate of production is relatively constant, and 
is not affected by changes in diet. Most studies report no association between CysC levels 
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and gender, age or muscle mass, but higher CysC levels with male gender, older age, and 
greater height and weight were noted in at least one study. Although reference ranges 
have been reported, there is no current standard for plasma CysC measurements. 
Preliminary evidence has indicated that serum levels of CysC are influenced by 
corticosteroid use, by age, sex, weight, height, smoking status and the level of C-reactive 
protein. 
A number of radioimmunoassays and fluorescent or enzymatic immunoassays41 
can be used to measure CysC. But their widespread clinical use is not feasible because 
these methods are slow. Latex immunoassays employ latex particles conjugated to CysC 
specific antibody. These assays demonstrate greater precision, produce more consistent 
reference intervals, and are far quicker42. Particle enhanced turbid metric immunoassay    
(PETIA) 43 and particle enhanced nephelometric immunoassay (PENIA) 44 are the 
available versions. Nephelometric assays are superior to others.  
The plasma CysC concentration may correlate more closely with the GFR than 
the plasma creatinine concentration. In multiple studies, plasma CysC was more sensitive 
in identifying mild renal insufficiency than plasma creatinine45. Using radioactive 
iothalamate clearance as the gold standard, serum CysC levels began increasing at GFR 
levels of approximately 88 ml/min per 1.73 m2, while the plasma creatinine concentration 
only increased when the GFR was approximately 75 ml/min per 1.73 m2 46.  
A meta analysis by Dharnidharka VR et al in 2002, incorporating 46 original 
articles and 8 abstracts and using standard measures of GFR suggested superiority of 
reciprocal CysC values over reciprocal serum creatinine level as a marker of GFR47. 
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Estimation equations based on plasma CysC have also been formulated48, 49. 
CysC-based equations also appear to be more accurate among renal transplant 
recipients50, 51 and patients with cirrhosis52. Whether CysC correlates better with GFR 
than plasma creatinine concentration in patients with diabetic nephropathy is unclear53, 54.  
 
Grubbs equation55: 
GFR [ml /min per 1.73 m2] = 84.69 *CysC (mg/L)(-1.680) *1.384 (if a child <14 years) 
Parameter Finding Points 
Age < 14 yrs 1.384 
 ≥ 14 yrs 1 
GFR(ml/ min per 1.73 m2) = 87.62 * CysC (mg/L) (-1.693) * (points for age) * (points for 
gender) 
Parameter Finding Points 
Age < 14 yrs 1.376 
 ≥ 14 yrs 1 
Sex Male 1 
 Female 0.94 
The other equations available for use are the Lebricons’s, Hoek’s and Orlando’s. 
They are not as popular as the Grubb’s equation.  
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In summary, it appears that in certain populations, CysC may be more accurate 
for assessment of kidney function than plasma creatinine. Whether measurement of CysC 
levels will improve patient care is at present unknown. 
b) Radionuclide Markers  
The constant lookout for accurate markers to estimate clearance has yielded 
newer compounds. The radioactive tagged methods and the radio contrast methods are 
the important ones. 
A constant renal excretion has been demonstrated for at least three indicators 
namely, 125I-iothalamate, 125mTc-DTPA and 51Cr-EDTA. However errors in measurement 
have been reported. An underestimation is possible with 125mTc-DTPA due to plasma 
protein binding and overestimation with 51Cr-EDTA when intravenous injections are 
administered and blood is drawn from venous compartment56.  Single or multiple sample 
techniques are used to assess the clearance. Using monoexponential models, Tepe and co-
workers compared different sampling times for GFR determinations in 139 subjects57. 
They reported that a single-sample method was accurate and that sampling between 60 
and 240 minutes after injection was optimal. Others have also reported that single sample 
assessments are adequate58. Nevertheless, multiple sampling methods yield a more 
accurate and consistent values59. 
Plasma clearance can also be done without plasma sampling. A gamma camera is 
positioned over the kidneys and can be used to measure renal elimination of a radioactive 
indicator60, 61. The most commonly used substances in quantitative renal imaging are 
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99mTc-DTPA, radio iodinated iodohippurate (Hippuran), 123I-ortho-iodohippurate, or 
99mTc-mercaptoacetyltriglycine (MAG3)62. Computed tomography and magnetic 
resonance have also been suggested but are not precise for GFR estimation. 
The advantage of quantitative renal imaging is that additional information can be 
obtained pertaining to the anatomy of kidney function. The "split function" or relative 
contribution to total GFR from each kidney can be calculated using this method. The 
most commonly used substance to measure GFR is 99mTc-DTPA62. Owing to the chelate's 
instability, the radiolabelling of DTPA with 99m Tc must be carried out immediately 
before use. Samples must be counted soon after the procedure60 because the half-life of 
99mTc is only 6 hours. A significant source of error in some patients is due to the protein 
binding of 99mTc-DTPA63.   
These agents pose a risk of radioactivity to the collecting system. There are no 
long-term studies to assess this risk. It is advisable to avoid these agents in pregnancy and 
in children. 
c) Radiocontrast agents 
To avoid the use of radiolabelled compounds and with the availability of high 
performance liquid chromatography (HPLC), radiocontrast agents with low molecular 
weight have come into use for assessment of GFR. Iothalamate sodium, diatrizoate 
meglumine and iohexol are in use64. The major limiting factors are the expense of HPLC, 
the labour and the cost. The agents are considered safe even in high degrees of renal 
dysfunction. The extrarenal adverse effects are also fewer65.  
 29
Iohexol is the most popular agent in regular clinical use. Its properties of low 
osmolality and non-ionic nature have made it superior to others. Plasma clearance 
determinants are comparable to radionuclide markers and inulin66. 
Section II 
Voluntary kidney donors 
Renal transplantation depends on the successful transfer of kidneys from deceased 
donors, live related donors and live unrelated donors. In the western countries deceased 
donor donation has been the most common way of acquiring kidneys.  Because of the 
demand for organs, there is a considerable waiting period. To circumvent this problem, 
live donor transplantation is encouraged.  
An ideal voluntary kidney donor should have a near normal GFR. The practical 
difficulties enumerated above have made this evaluation difficult. One of the noninvasive 
methods like 99mTc-DTPA is used as a method for assessing the GFR. Iothalamate GFR 
may be more accurate, but is expensive. Creatinine based estimated GFRs are not 
reliable. The lower limit of renal function acceptable to donate needs to take into account 
of the fact that not only is the post-nephrectomy GFR will be approximately 75% of the 
predonation level, but also that there will be a decline in renal function with aging. 
Taking this into account, a lower limit of 80 ml/ min per 1.73 m2 has been proposed.  
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GFR in the Indian context 
Until now, a normal reference range for GFR in healthy adult Indians (usually 
evaluated in potential kidney donors) has not been determined and values from western 
population are being used as reference. In a study by Barai S et al67 in 610 patients (250 
males, 360 females, average age 35.16 years), it was observed that the mean GFRs in 
adult males and females were 82.3 ± 21.3 ml/min per 1.73 m2 BSA and 80.8 ± 18.1 
ml/min per 1.73 m2 BSA respectively. A 99mTc-DTPA two-plasma sample method of 
Russell was used in this study. Similar reports have been documented in one other 
study36. Observations in our institute have also been the same (unpublished data). We 
need better methods to confirm the above value as the reference GFR for our population.  
Glomerular filtration rates of Indian donors 
In India, the lack of knowledge and the socio-cultural issues have set limitations 
in acquiring cadaver organs for transplantation. Organs from live related or unrelated 
donors are the ones most often used for transplantation. 
As stated above, the normal GFR in the Indian population is not precisely known. 
The value is presumed to be considerably lower than the western population. A few 
studies including one from this center (unpublished) using the DTPA based methods have 
shown the value to be approximately about 80-90 ml/ min per 1.73 m2. 
 To ensure the safety of donors and for medicolegal aspects, it is important to 
document the renal functions prior to nephrectomy. The various methods like DTPA 
clearance or scintigraphy and the estimations equations have been utilized in these 
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normal adults. These estimations are not accepted in the western countries for assessing 
donors. In India, monetary limitations are often quoted as a reason for not performing 
these evaluations prior to transplantation. Also, because of the considerable variations in 
the sensitivities of the investigations for accurate assessment, the decision on the choice 
of test remains questionable. 
Studies have been performed to look at the applicability of estimations using 
creatinine based equations. One such study by Mahajan et al68 looked at 173 voluntary 
kidney donors. The predictive capabilities of the CG equation for creatinine clearance 
(CrCl) corrected for body surface area (CGCrCl), CGCrCl corrected for GFR (CGGFR), 
MDRD1, MDRD2 and urineCrCl were evaluated with 99mTcDTPA-GFR as reference 
GFR. The study population had a mean age of 44.1 years with 74% being females. The 
conclusion derived in this study was that, the poor correlation and level of error exhibited 
by these equations makes them suboptimal for donor evaluation68. 
Post-Nephrectomy GFR 
The glomerular filtration rate in these donors is expected to decline after the 
uninephrectomy for transplantation. However, there will be a compensatory hypertrophy 
of the surviving kidney to augment the GFR. A few studies have observed this effect. 
Pabico RC et al noted a post-nephrectomy increase in GFR by 36%69. Ibrahim HN et al. 
have proposed that MDRD formula can be used for accurate prediction of GFR after 
nephrectomy70. The GFR was measured using iohexol in this study.  
This data has not been studied in Indian context previously. The major limitation 
is the accuracy of the test to be employed. 
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Use of CysC 
In a recent study by Herget- Rosenthal et al, they observed CysC to predict 
changes in the GFR more accurately than serum creatinine. They concluded that serum 
CysC detects rapid GFR decreases one to two days earlier than creatinine71.  
However there are quite a number of studies available that have found that CysC may not 
be all that effective. In one such study from our centre by John GT et al72, it was 
concluded that because of its large intraindividual variations, serial serum CysC 
estimation was very poor in detecting reduced renal function. Thus the role of CysC in 
clinical use is still undecided in voluntary kidney donors.  
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Aims of the study 
1. To compare the measured GFR (99mTc DTPA) and the estimated GFR (Creatinine 
and Cystatin C) by various methods in voluntary kidney donors. 
a. Before donor nephrectomy  
b. After donor nephrectomy 
2. To analyze the consistency of the various methods to assess the decline in GFR. 
3. To study the residual GFR of the solitary kidney after compensation (after 3 
months and before 6 months of nephrectomy). 
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Methodology 
The study was conducted in the Department of Nephrology, Christian Medical 
College. The subjects enrolled were the voluntary kidney donors who were accepted by 
the department for kidney donation after all the investigations were done. These patients 
were informed about the study and informed consent was obtained. If they were willing 
for the reevaluation after 3 months interval, they were enrolled as part of the study. 
The 99mTCDTPA scans were done with the help of the Department of Nuclear 
medicine and the biochemical investigations including cystatin C were performed by the 
Department of Biochemistry. The data was analyzed with the help of the Department of 
Biostatistics. 
Sample Size 
Table 2: Sample Size derivation 
 
Parameter 
 
Value 
 
Sample reliability value 
 
 
0.83 
 
Population reliability value 
 
 
0.95 
 
Study sample size 
 
 
21 
 
Alpha error 
 
 
5 
 
Power obtained 
 
 
82% 
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Patients 
The study sample included 43 patients. 
Inclusion criteria 
¾ Age >20 and <65 years 
¾ Non hypertensives 
¾ Absence of other co morbid conditions 
¾ No previous history of any renal disease 
¾ No urological abnormalities 
¾ Willingness to undergo the procedure 
Exclusion Criteria: 
 Inability to come after 3 months to undergo the follow-up investigations. 
 They were also excluded if they had developed any other medical problem that 
might influence the study outcome. 
Biochemical Investigations 
Estimation of creatinine 
Colorimetric, kinetic Jaffe, alkaline picrate without deproteinisation 
Principle: 
Creatinine + Picric acid--------------------Creatinine picramate 
Explanation: 
Creatinine in the serum forms a coloured complex with picrate in alkaline 
solution. The rate of absorbance change of the coloured complex is proportional to the 
creatinine concentration. 
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Estimation of urea 
 
Colorimetric, enzymatic, end point, urease, Berthelot’s reaction 
 
Principle: 
 
Urea+H2O-------------------------2NH3 + CO2 
 
Explanation: 
 
Urease breaks down urea to produce ammonia which reacts with salicylate and  
 
hypochlorite to give a coloured complex with sodium nitroprusside as a catalyst 
 
 
Whenever BUN was needed for evaluation it was calculated by dividing the blood 
urea by the factor of 2.1 
Estimation of Albumin 
Colorimetric, end point bromocresol green (BCG) 
Principle: 
BCG + Albumin-------------------------------Complex with colour change 
Explanation: 
BCG is a yellow indicator which binds to albumin with a colour change from 
yellow to blue green. Turbidity is avoided by addition of Brij- 35 
Estimation of Cystatin C 
Particle enhanced nephelometry 
Principle: 
Polystyrene coated with specific antibodies to human cystatin C is aggregated 
when mixed with particles containing human cystatin C. These aggregates scatter a beam 
of light passing through the sample. The intensity of the scattered light is proportional to 
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the concentration of the relevant protein in the sampler. The result is evaluated by 
comparison with a standard of known concentration. 
99mTc-DTPA Renal scan 
This was performed on the patients after the administration of 130 MBq of the 
radioactive isotope and the scans were performed based at specified time intervals. The 
GFR was estimated using the Gates method of analysis using softwares designed for the 
calculation. Depth calculation was done by the standards used in the formula. 
 
Estimation of GFR 
The Equations used for estimation of GFR were:  
CGCrCl: 
a) Men: CrCl = [(140-age)* Weight (Kg)]/[SCr * 72] * BSA/1.73 m2 
b) Women: CrCl = [(140-age)* Weight (Kg)]/[SCr * 72] * 0.85 * BSA/1.73 m2 
(The actual body weight and the lean body weight were used for the estimation 
separately) 
CGGFR estimate:  
CGGFR = 0.84 * CGCrCl 
MDRD1: 
GFR = 170 * [SCr] -0.999 *[age] -0.176 *[0.762, for female] *[1.18, for blacks] 
*[BUN] -0.170 *[ALB] 0.318 
MDRD2: 
GFR: 186 *[SCr] -1.1154 *[age] -0.203 *[0.742, for female] *[0.212, for blacks] 
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• The values were obtained by substituting the parameters in computer-generated 
programs. 
• All the GFR values were standardized for the surface area of 1.73 m2 for 
comparison. 
• The  actual and lean body weights were used for calculating CGGFR (CGGFRA 
and CGGFRL). 
 
Statistical Analysis 
Statistical analysis was performed using the SPSS software version 9. 
An intraclass correlation coefficient (Two way random method) was calculated 
for the measured and the predicted values and between the several predicted values and 
their significance was determined.  
This data were done separately for the pre and the post nephrectomy data.  
The significance of the decline in the post nephrectomy value was compared with 
the pre-nephrectomy value using the students Paired ‘t’ test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 39
Observation and Results 
 
The 99mTC-DTPA renal scintigraphy was considered the gold standard for GFR 
assessment. It was compared with the estimated GFRs of MDRD and CG formulae 
(creatinine based). These two analyses were performed before and after nephrectomy. 
CysC was done in 21 patients and the GFR was compared in this subset against the 
99mTC-DTPA method. Table 3 summarizes the details. 
 
 
Table 3: Sample and the investigations done in them 
 
Variable 
 
 
Number 
 
Total number of patients 
 
 
43 
 
 
99m TC-DTPA scintigraphy 
 
 
43 
 
 
Calculated GFR 
 
43 
 
 
Cystatin C 
 
21 
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The anthropometric parameters of the subjects are summarized in Table 4. The 
actual body weight (CGGFRA) and the lean body weight (CGGFRL) were used for 
calculation of the GFR by the CG method.  The MDRD1 and MDRD2 equations were 
also used. CysC based GFR was calculated by the Grubb’s equation. All the GFRS were 
adjusted to 1.73 m2.  
 
 
Table 4: Demography and Anthropometry 
 
 
 
Variable 
 
 
Result 
 
Mean Age (years) 
 
 
43.02 ± 12.05 
 
Sex ratio (M/F) 
 
 
15/28 
 
Weight (Kg) 
 
 
57.84 ± 10.74 (38-80) 
 
Lean body weight (Kg) 
 
 
43.51 ± 7.5 (31-59) 
 
Height (cm) 
 
 
157.35 ± 7.8 (140-175) 
 
BSA (m2) 
 
 
1.57 ± 0.16 (1.27- 1.89) 
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Males constituted about one third of the study sample. The mean age of the 
population was 43.02 ± 12.05 years. The post-nephrectomy evaluation was done after 3 
months and before 6 months. 
 
Pre-nephrectomy studies 
 
The pre-nephrectomy GFR was measured by the 99m TC-DTPA method.  A mean 
of 92.37 ± 26.79-ml/min per 1.73 m2 was obtained for the study group of 43 patients. 
The CG formula based methods gave a estimated GFR with actual and lean body weights 
as 78.34 ± 16.30 and 58.12 ± 12.35 ml/min per 1.73 m2 respectively and the MDRD1 and 
MDRD2 GFRs were 84.61 ± 15.68 and 90.82 ± 19.29 ml/min per 1.73 m2 respectively. 
The data are summarized in the Table 5. 
A pictorial representation of the data is given in the diagram that follows. (Figure 4) 
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Table 5:  Pre-nephrectomy measured and estimated GFRs for the entire population 
 
 
Variable 
 
 
Mean 
 
SD 
 
Min 
 
Max 
 
Creatinine¶ 
 
00.84 
 
00.15 
 
0.6 
 
01.10 
 
DTPA * 
 
 
92.37 
 
26.79 
 
45.00 
 
159.00 
 
CGGFRA* 
 
 
78.34 
 
16.30 
 
47.00 
 
110.00 
 
CGGFRL* 
 
 
58.12 
 
12.35 
 
31.64 
 
88.11 
 
MDRD1* 
 
 
84.61 
 
15.68 
 
50.92 
 
130.90 
 
MDRD2* 
 
 
90.82 
 
19.29 
 
53.00 
 
134.00 
 
* ml/min/1.73 m2                    ¶ mg/dl                              
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Figure 4. Box plot of the pre-nephrectomy GFR by various methods 
 
 
The mean CysC based GFR was 90.48 ± 28.04 ml/min/1.73m2. This compared to 
the 99mTC-DTPA GFR of 101.19 ± 29.76-ml/min/1.73 m2 in this subset. The data are 
summarized in the table 6 and is depicted pictorially in figure 5. 
 
 
 
 
 
 
 44
Table 6: Pre-nephrectomy GFR in the subset with CysC  
 
 
Variable 
 
 
Mean 
 
SD 
 
Min 
 
Max 
 
Creatinine¶ 
 
 
0.88 
 
0.12 
 
0.7 
 
1.1 
 
DTPA * 
 
101.19 
 
 
29.71 
 
48 
 
159 
 
CGGFRA* 
 
 
75.96 
 
 
16.13 
 
47.78 
 
102.73 
 
CGGFRL* 
 
56.84 
 
 
12.47 
 
31.64 
 
82.06 
 
MDRD1* 
 
81.25 
 
 
14.28 
 
50.93 
 
107.15 
 
MDRD2* 
 
87.00 
 
 
18.89 
 
53.15 
 
134.55 
 
GFRCysC* 
 
90.48 
 
 
28.04 
 
48.94 
 
140.32 
 
* ml/min/1.73 m2                    ¶ mg/dl                              
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Figure 5: Box plot of GFRs in the subset with CysC 
 
 
 
 
 
 
 
An intraclasss correlation coefficient was derived between the various methods. 
The correlation coefficient was significant between the various estimated GFRs but none 
of them fared well against the 99mTC-DTPA GFR. The details are in table 7 
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Table 7: Pre-nephrectomy intraclass correlation coefficient for the different GFR 
values 
 
 
 
Variable 
 
 
ICC * 
 
95% CI 
 
 
 
P 
  
Min 
 
 
Max 
 
DTPA- 
CGGFRA 
 
 
0.24 
 
 
-0.05 
 
0.50 
 
0.54 
 
DTPA- 
CGGFRL 
 
 
0.12 
 
 
-0.17 
 
0.41 
 
0.20 
 
DTPA- 
MDRD1 
 
 
0.11 
 
 
 
-0.19 
 
0.39 
 
0.23 
 
DTPA- 
MDRD2 
 
 
0.13 
 
 
-0.16 
 
0.41 
 
0.19 
 
MDRD1-
MDRD2 
 
 
0.90 
 
 
0.83 
 
0.94 
 
0.000 
 
CGGFRA- 
MDRD1 
 
 
0.70 
 
 
0.51 
 
0.82 
 
0.000 
 
CGGFRA- 
MDRD2 
 
 
0.80 
 
 
0.66 
 
0.88 
 
0.000 
 
CGGFRL- 
MDRD1 
 
 
0.90 
 
 
0.82 
 
0.94 
 
0.000 
 
CGGFRL-
MDRD2 
 
 
0.81 
 
 
0.68 
 
0.89 
 
0.000 
* ICC- Intraclass correlation coefficient 
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In the subset involving cystatin C, a similar analysis was done. The correlation 
coefficient of 0.83 was derived between 99mTC-DTPA and CysC GFRs that indicates 
good correlation. The values are shown in the Table 8. 
 
Table 8: Pre-nephrectomy intraclass correlation coefficient for the subset with CysC 
 
 
 
 
Variable 
 
 
ICC * 
 
95% CI 
 
 
 
P  
Min 
 
 
Max 
 
DTPA- 
GFRCysC 
 
 
0.83 
 
0.64 
 
0.93 
 
0.00 
 
GFRCysC- 
CGGFRA 
 
 
0.23 
 
-0.21 
 
0.59 
 
0.15 
 
GFRCysC- 
CGGFRL 
 
 
0.05 
 
-0.37 
 
0.46 
 
0.40 
 
GFRCysC- 
MDRD1 
 
 
0.00 
 
-0.42 
 
0.42 
 
0.50 
 
GFRCysC- 
MDRD2 
 
 
0.00 
 
-0.41 
 
0.42 
 
0.48 
 
* ICC- Intraclass correlation coefficient 
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Post-nephrectomy studies 
 
A similar analysis was performed in the post-nephrectomy period.  The 99mTC-
DTPA study was obtained and the biochemical parameters were repeated. The CG and 
MDRD equations were again used to calculate the GFRs. 
 
Table 9: Postnephrectomy measured and estimated GFRs for the entire population 
 
 
 
 
Variable 
 
Mean SD Min Max 
Creatinine¶ 
 
01.19 
 
00.20 00.90 01.50 
DTPA* 
 
53.58 
 
17.18 23.00 101.0 
CGGFRA* 
 
56.78 
 
12.90 34.58 84.05 
CGGFRL* 
 
42.42 
 
10.00 23.55 67.14 
MDRD1* 
 
62.07 
 
11.34 39.21 90.26 
MDRD2* 
 
61.67 
 
12.33 38.22 91.71 
 
* ml/min/1.73 m2                    ¶ mg/dl                              
 
 
The mean 99mTC-DTPA GFR for the patients after nephrectomy was 53.58 ± 
17.18-ml/min/1.73 m2. The CGGFRA, CGGFRL, MDRD1 and MDRD2 GFRs were 
estimated at 56.78 ± 12.90, 42.42 ± 10.10, 62.07 ± 11.34 and 61.67 ± 12.33 ml/min/1.73 
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m2 respectively. The data are summarized in table 9 (above) and a pictorial representation 
is shown in figure 6(below). 
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Figure 6: Box plot of the post-nephrectomy GFR by various methods 
 
 
For the subset of 21 patients, who had the CysC, a mean of 54.85 ± 19.40 and 
56.73 ± 15.87 ml/min/1.73 m2 were obtained for 99mTC DTPA and CysC GFRs. Details 
are depicted in the table 10 and a pictorial representation is shown in figure 7 
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Table 10: Post-nephrectomy measured and estimated GFR in the subset with CysC 
studies 
 
 
 
Variable 
 
Mean SD Min Max 
Creatinine¶ 
 
1.16 
 
0.18 0.9 1.5 
DTPA*  54.85 
 
19.40 29 101 
CGCGFA*  58.04 
 
12.78 37.72 84.05 
CGGFRL* 
 
40.87 
 
13.38 25.42 67.14 
MDRD1*  62.73 
 
10.83 41.57 87.69 
MDRD2*  62.57 
 
11.78 40.24 89.81 
GFRCysC  56.73 
 
15.87 28.29 94.85 
 
* ml/min/1.73 m2                    ¶ mg/dl                              
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Figure 7: Box plot of post-nephrectomy GFRs in the subset with CysC 
 
 
 
 
Similar to the pre-nephrectomy study an intraclass correlation coefficient was 
obtained between the measured and the estimated values. A similar correlation coefficient 
was obtained at this stage also. Though there was no correlation between any of the 
measured and estimated values, a reasonable correlation was obtained between the 
different estimated GFRs.  The coefficients are shown in table 11 
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Table 11: Post-nephrectomy Intraclass correlation coefficient for the different GFR 
values 
 
 
 
 
Variable 
 
 
 
ICC * 
 
95% CI 
 
 
 
 
p 
 
 
Min 
 
Max 
 
 
DTPA- 
CGGFRA 
 
 
0.21 
 
-0.08 
 
 
0.48 
 
0.07 
 
DTPA- 
CGGFRL 
 
 
0.22 
 
-0.07 
 
 
0.49 
 
0.06 
 
DTPA- 
MDRD1 
 
 
0.31 
 
0.01 
 
 
0.55 
 
0.01 
 
DTPA- 
MDRD2 
 
 
0.18 
 
-0.12 
 
 
0.45 
 
0.11 
 
MDRD1-
MDRD2 
 
 
0.68 
 
0.48 
 
0.81 
 
0.00 
 
CGGFRA- 
MDRD1 
 
 
0.83 
 
0.71 
 
0.90 
 
0.000 
 
CGGFRA- 
MDRD2 
 
 
0.58 
 
0.34 
 
0.75 
 
0.00 
 
CGGFRL- 
MDRD1 
 
 
0.94 
 
0.90 
 
0.97 
 
0.00 
 
CGGFRL-
MDRD2 
 
 
0.58 
 
0.35 
 
0.75 
 
0.00 
* ICC- Intraclass correlation coefficient 
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The correlation coefficient between CysC and the other GFRS is given below 
(Table 12).    
A good correlation was obtained with the measured GFR. 
 
 
Table 12: Post-nephrectomy intraclass correlation coefficient for the subset with 
CysC 
 
 
 
 
Variable 
 
 
ICC * 
 
95% CI 
 
 
 
P 
 
 
Min 
 
 
Max 
 
DTPA-
GFRCysC 
 
 
0.67 
 
 
0.34 
 
0.85 
 
0.00 
 
GFRCysC-
CGGFRA 
 
 
0.12 
 
 
-0.31 
 
0.52 
 
0.28 
 
GFRCysC- 
CGGFRL 
 
 
-0.43 
 
 
-0.72 
 
0.00 
 
0.97 
 
GFRCysC- 
MDRD1 
 
 
0.00 
 
 
-0.41 
 
0.42 
 
0.48 
 
GFRCysC- 
MDRD2 
 
 
0.02 
 
-0.40 
 
0.44 
 
0.45 
 
• ICC- Intraclass correlation coefficient 
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The pre- and the post- nephrectomy GFRs were compared and the percentage of 
decline  
GFR in the post nephrectomy period was studied by each method. The data are 
summarized in table 13 
 
 
 
 
Table 13.  Post-nephrectomy GFR compared to the pre-nephrectomy value 
 
 
Variable 
 
 
Pre-neph 
 
Post-neph 
 
Diff 
% 
Decline 
 
P 
 
Creatinine¶  
 
 
0.84 
 
1.19 
 
 
00.32 ±  
0.14 
  
 
DTPA* 
 
 
92.37 
 
53.58 
 
 
38.79 ± 
23.56 
 
41.99 
 
0.00 
 
CGGFRA* 
 
 
78.34 
 
56.78 
 
 
21.56 ± 
11.11 
 
27.52 
 
0.00 
 
CGGFRL* 
 
58.12 
 
42.42 
 
 
16.24  ± 
8.29 
 
27.94 
 
0.00 
 
MDRD1* 
 
84.61 
 
62.07 
 
 
22.53 ± 
13.08 
 
26.63 
 
0.00 
 
MDRD2* 
 
90.82 
 
61.67 
 
 
29.15 ± 
15.85 
 
32.09 
 
0.00 
 
GFRCysC * 
 
90.48 
 
56.73 
 
 
33.68 ± 
 8.70 
 
37.30 
 
0.000 
 
* ml/min/1.73 m2                    ¶ mg/dl                              
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Discussion 
 
Voluntary kidney donors have a subnormal renal function after nephrectomy due 
to the renal donation. This puts them at a compromised state and makes them more 
vulnerable for renal failure when exposed to nephrotoxic insults. It is proposed that all 
donors should have their GFR evaluated prior to donor nephrectomy. This assures their 
suitability for organ donation. Some studies have also suggested that the kidney with the 
lower GFR as studied by split function may be used for transplantation73.  
As direct measurements of GFR are cumbersome, the Nephrologists rely on 
methods using isotopes to give a fairly accurate GFR. The estimation equations have also 
been validated in this population (who are apparently normal) and have not been found 
useful.  
GFR is not well known in the Asians and particularly in the Brown Caucasians of the 
Indian subcontinent. Though a few studies are available, they are inadequate in the 
sample and the methods used.  
We have approached this study with an aim to see if there is a correlation in the 
GFRs using the 99mTc-DTPA renal scintigraphy, which is the most easily available and 
routinely used in most centres, and the major prediction equations postulated by the 
K/DOQI namely CG and MDRD equations. These data are analysed in the pre- and the 
post-nephrectomy settings.  
Also, the residual kidney left behind undergoes adaptive hyperfiltration and 
hypertrophy as following any nephron loss. The hyperfiltraion augments the GFR. This 
has also been analysed in previous studies. We attempted to quantify this augmentation 
by the methods we used. 
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Our first observation was that the average GFR for our population is 92.37 ± 
26.79 ml/min/1.73 m2 compared to the mean measured GFR of 112.8 ml/min per 1.73 m2 
(range, 70.0 to 169.0 ml/min) in a study by Julie Lin et al from Boston28. A similar study 
on healthy donors from Delhi also showed a mean DTPA-GFR was 83.85-ml/min/1.73 
m2 by DTPA clearance method, which is more comparable to our study68. As a method 
like inulin clearance is not available, this is the closest that we can reach to predict 
normal GFR in the Indian population.  The reasons for the lower value may be because of 
the smaller build and the muscle mass of the Indian population.  
However, the confounding factors in this method are that the software that is used 
for computing the GFR based on the renal accumulation of the contrast is not 
standardized to the Indian population and the depth correction is calculated for guidelines 
derived from the western data. This may significantly influence the outcome of the study. 
We are trying to standardize this parameter for improving the accuracy for future studies. 
Again, the 99mTC-DTPA is not stable and has to be prepared just prior to injection and 
there may be inter-batch variability in the radioactivity. Extravasations have to be 
carefully accounted prior to calculations.  
The CG formula and the MDRD formula are again derived for the white and 
black populations. They are standardized in the Western population but similar data are 
lacking in the Indian context. The previous study quoted above from Delhi attempted at 
similar correlations as in our study68. But the estimations did not match up to the 99mTC-
DTPA. Furthermore CG based method is expected to be more accurate at the higher GFR 
range (Pre-nephrectomy) and the MDRD equation depicts the GFR better in the lower 
range of GFR (Post-nephrectomy) because of the inbuilt bias in their derivation. Also, the 
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lean body weight is suggested more accurate for calculation of GFR using the CG 
method. 
In our study, while using the CG formula, the GFR was obtained using both the 
actual and the lean body weights. It was estimated at 78.34 ± 16.30 and 58.12 ± 12.35 
ml/min/1.73 m2 for the actual and lean weights respectively. 
The MDRD method calculated a mean GFR of 84.61 ± 15.68 and 90.82 ± 19.29-
ml/min/1.73 m2 by the two equations.  
When an intraclass correlation coefficient was attempted between the two groups, 
there was no significance between the measured and the estimated values. However there 
was a reasonable degree of correlation between the various estimation equations. The 
MDRD equations had a high degree of correlation and hence MDRD2 can be used in all 
places as it much simpler to calculate.  
The inference derived after the pre-nephrectomy studies are that the GFR in the 
Indian population is much less compared to the western data. Assuming that there are no 
fallacies in the measurements, the estimations fare poorly against it. The CG estimation is 
equally worse. 
The second half of the study looked at a similar assessment after a period of 3 
months from the time of nephrectomy. This time limit was arbitrarily chosen with the 
knowledge that the GFR declines in the immediate post nephrectomy phase and the 
compensations take place over a two to four week period. Hence analyses were done after 
a considerable time gap to find out the stable compensated GFR in the residual kidney.  
The post-nephrectomy GFR by the 99mTc-DTPA was 53.58 ± 17.18-ml/min/1.73 
m2 . The comparative estimations were 56.78 ± 12.90, 42.42 ± 10.10, 62.07 ± 11.34 and 
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61.67 ± 12.33 ml/min/1.73 m2 by CGGFRA, CGGFRL, MDRD1 and MDRD2 methods. 
The intraclass correlation between measured and estimated values was not significant.  
The conclusions derived at this stage are that the post-nephrectomy estimations 
are also not very useful in assessing the measured GFR. 
To improve the analysis, it was decided to check CysC based GFR as serum CysC 
is known to reflect smaller changes in GFR than creatinine based methods. A subgroup 
analysis was carried out and it was detected that the CysC had a good correlation with the 
DTPA method. 
It was found that the GFR using CysC substitution of the Grubb’s equation was 
accurate in predicting the measured GFR in both the pre- and post- nephrectomy settings. 
In a study from the Netherlands by Rook M et al74, the post-nephrectomy GFR from 
donors after 57 ± 6 days was 64 ± 7% indicating an approximate decline of 36 %. After 
kidney donation, ter Wee et al75, also from the Netherlands, obtained a similar median 
value of 65% of its initial value (Indicating a decline of 35%).  
Similar declines were obtained in our study with the 99mTC-DTPA method recording 
the biggest decline. A comparison between the pre-nephrectomy and the post-
nephrectomy GFRs were made. There was a consistent decline in each of the methods. 
The post-nephrectomy GFR decline was 41.99% by 99mTc-DTPA. It was approximately 
27.52 % and 27.94% using CG method (actual and lean weights) and 26.63 and 32.09 % 
by MDRD1 and MDRD2 methods. This decline was statistically significant. The decline 
was about 37.30 % by CysC method. 
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Summary 
 
Forty-three donors (15 males, mean age of 43.02 ± 12.05 years) were studied. CG 
estimations used actual and lean body weight (CGGFRA, CGGFRL). Modification of 
diet in renal diseases formula used MDRD1 and MDRD2 formulae. The measured values 
were 92.37 ± 26.79-ml/min/1.73 m2 at baseline and 53.58 ± 17.18-ml/min/1.73 m2 after 3 
months. The estimated values at the same time points by CGGFRA, CGGFRL, MDRD1 
and MDRD2 were 78.34 ±16.30, 58.12 ±12.35, 84.61± 15.68, 90.82 ± 19.29 ml/min/1.73 
m2 respectively, pre-nephrectomy and 56.78 ± 12.90, 42.42 ± 10.00, 62.07 ± 11.34 61.67 
± 12.33 ml/min/1.73 m2 respectively, post-nephrectomy. As CysC is better predictor of 
changes in GFR, it was performed in a subset (n=21). The Pre- and post-- nephrectomy 
CysC GFR using the Grubb’s equation was 90.48 ± 28.04 and 56.73 ± 15.87- 
ml/min/1.73 m2. Significant intraclass correlation coefficient was noted between 
99mTCDTPA GFR and CysCGFR (0.83 and 0.67, pre and post), but not with others. CG 
and MDRD GFRs had correlation. Post-nephrectomy GFR decline by all methods were 
significant with 99mTCDTPA GFR (41.99%) recording the maximum decline. 
All the methods reflected the decline in GFR. But there were differences in the 
degree of decline reflected by each of these methods. 
The inferences derived were that creatinine based estimations are not accurate in 
predicting measured GFR both in the pre-nephrectomy period (apparently normal) and in 
the period after donor nephrectomy (when GFR is impaired). However, Cystatin C based 
GFR measurements had reasonable correlation to predict the GFR.  
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Conclusions 
 
 
 
 
1. The measured GFR (99mTcDTPA scintigraphy) does not correlate with the 
creatinine based estimated GFR values. This holds good before and after donor 
nephrectomy. 
2. The Cystain C based GFR has relevance to the measured GFR (99mTcDTPA 
scintigraphy) before and after nephrectomy. 
3. CGGFR correlates with MDRD GFR before and after nephrectomy. 
4. The post nephrectomy GFR decline is reflected by all methods. The decline in 
DTPA is greater compared to the creatinine and Cystatin C methods. 
 
 
.  
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